Regulus Reports First Quarter 2017 Financial Results and Corporate Restructuring

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. MU
6. FDX
7. IBM
8. PRIM
9. PFE
10. ACN

Go back to Regulus Reports First Quarter 2017 Financial Results and Corporate Restructuring
REGULUS THERAP (NASDAQ: RGLS) Delayed: 8.16 --0 (-0%)
Previous Close $8.16    52 Week High $10.60 
Open $8.16    52 Week Low $2.13 
Day High $8.16    P/E 0.21 
Day Low $8.16    EPS $38.45 
Volume 3,167